International Workshop on non-Hodgkin Lymphoma (iwNHL), 6-8 May 2021

VJHemOnc is pleased to be the official media partner for iwNHL 2021, an event encouraging interactive debates and discussions on non-Hodgkin lymphoma (NHL) and related disorders in a workshop environment.

This workshop will highlight efforts to understand the biology of different NHL subtypes to further refine therapeutic strategies. Some of the world’s leading clinical researchers in NHL will share their perspectives on how to place this evolving understanding in a clinical context and thereby optimize clinical care.

This event is for hematologists, researchers, nurses, and allied medical professionals only. Please apply for registration by filling in the form and confirming your details. We will review your application and confirm your registration on submission.
By applying, you confirm that your details are correct and that the organizer can communicate with you regarding this event.

Thursday: May 6, 2021

10:00 (EST)

Day 1: Introduction & Virtual Meeting Objectives
John Gribben

10:10 -11:30

Session I:  T-Cell Lymphoma

Chairs: Laurence de Leval & Francine Foss

  • EBV-associated lymphoproliferations:
    • Pathobiology and Spectrum; Elaine Jaffe
    • Clinical Perspective; Arnaud Jaccard 
  • Biology clinics and management of breast implant-associated ALCLs
    • experience from the French registry; Corinne Haioun
  •  Update and perspectives for epigenetic modifier therapy in PTCLs; Lorenzo Falchi

Roundtable discussion

 

11:30 – 1:00

Session II: Immunotherapy/Microenvironment

Chairs: David Maloney & Stephen Ansell

  • Targeting the Immune Microenvironment; Massimo Di Nicola
  • Crosstalk between lymphocytes and their microenvironment; Patricia Pérez Galán
  • CBT in specific lymphoma subtypes; Stephen Ansell
  • ROR1 CARs and the tumour microenvironment; Stan Riddell
  • IMIDS in combination; Alexandra Albertsson-Lindblad
  • Checkpoint Inhibitors; Scott J. Rodig

Roundtable discussion

 

1:00

End Day 1: Roundup of Day 1:
John Gribben, David Maloney, Laurence De Leval, Stephen Ansell, Francine Foss

Friday: May 7, 2021

10:00 – 10:10

Day 2: Introduction
John Gribben

10:10 – 11:20

Session III: Mantle Cell Lymphoma

Chair: Elaine Jaffe

  • Introduction; Elaine Jaffe
  • Keynote Speaker; Elias Campo

Roundtable Discussion

 

11:20 – 1:15

Session IV: Novel Therapies Part I

Chairs: Laurie Sehn & Franck Morschhauser

  • ADCs:
    • Polatuzumab vedotin; Laurie Sehn
    • Loncastuximab TesirineBrad Kahl
    • ADCT301 camidanlumab tesirine; Graham Collins
  • CD20/CD3 bispecific antibodies: How to choose?
    • Mosunetuzumab; Stephen J. Schuster
    • CD20 TCBFranck Morschhauser
    • REGN1979; Rajat Bannerji
    • DuoBody-CD3xCD20 (Epcoritamab); Tuna Mutis
  • Oral PI3K delta (δ) inhibitors in lymphoma; Jennifer Brown

Roundtable Discussion

 

1:15

End Day 2: Roundup of Day 2:
John Gribben, Laurie Sehn, Franck Morschhauser, Elias Campo

Saturday: May 8, 2021

10:00 – 10:10

Day 3: Introduction
John Gribben

10:10 – 12:00

Session V: Novel Therapies Part II

Chairs: Gilles Salles & Sonali Smith

  • Novel BTK inhibitors: how to choose?
    • Ibrutinib combinations; Paolo Ghia
    • Zanubrutinib; Michael Wang
    • Acalabrutinib; Tom Witzig
    • Loxo-305; Anthony Mato
    • Tirabrutinib; Alexey Danilov
  • SINE inhibitors: Selinexor; Sundar Jagannath
  • Tafasitamab (MOR208) in DLBCL; Gilles Salles

Roundtable Discussion

 

12:00 – 1:45

Session VI: T-cell Therapies for Lymphoma

Chairs: Cath Bollard & Jeremy Abramson

  • CD19-CAR- T cells:
    • Lisocabtagene maraleucel (liso-cel) in DLBCL; Jeremy Abramson
    • Axicabtagene ciloleucel (axi-cel) in DLBCL; Sattva S. Neelapu
    • Tisagenlecleucel in DLBCL; Stephen Schuster
  • CD30-CAR T cells; Barbara Savoldo
  • CD5 and/or 7 CAR T cells; Max Mamomkin
  • Antigen-specific T cell Overview; Cath Bollard
  • Third party EBV T cells; Susan Prockop

Roundtable Discussion

1:45

End Day 3: Virtual Meeting Summary & Conclusions
iwNHL Scientific Committee 

This event is for hematologists, researchers, nurses, and allied medical professionals only. Please apply for registration by filling in the form and confirming your details. We will review your application and confirm your registration on submission. By applying, you confirm that your details are correct and that the organizer can communicate with you regarding this event.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter